Literature DB >> 8357529

Cholecystokinin-dopamine interactions within the nucleus accumbens in the control over behaviour by conditioned reinforcement.

G D Phillips1, J Le Noury, G Wolterink, I Donselaar-Wolterink, T W Robbins, B J Everitt.   

Abstract

Cholecystokinin (CCK) is colocalised with dopamine in the postero-medial nucleus accumbens (NAS). We have utilised an acquisition of a new response procedure to investigate the interaction between CCK and dopamine in the control over behaviour by conditioned reinforcers. A conditioned reinforcer (CR) may be defined as an initially neutral stimulus which gains control over behaviour through selective association with a primary reinforcer. Here, rats learned to associate a light/noise compound stimulus with the imminent availability of 10% sucrose reinforcement. Later, in the absence of sucrose, responding on one of two novel levers (the CR lever) was acquired and maintained by contingent presentation of the CR alone, while responding on the second lever had no programmed consequences. In Expt. 1, infusion of 10 micrograms D-amphetamine within the postero-medial NAS enhanced responding selectively on the CR lever. Infusion of sulphated CCK octapeptide (CCK: 1 or 10 ng) alone within the same area had no effect on response rate. However, infusion of CCK immediately prior to D-amphetamine caused a dose-dependent potentiation of the impact of D-amphetamine upon rates of response on the CR lever. In Expt. 2, infusion of D-amphetamine (10 micrograms) within the postero-medial NAS again enhanced responding selectively upon the CR lever. Intra-accumbens infusion of CCK (10 ng), or s.c. administration of the CCKA receptor antagonist devazepide had no effect upon response rates. However, CCK again potentiated the D-amphetamine-induced increase in rates of response, and this potentiation was blocked by pretreatment with devazepide. These results are discussed in terms of the co-modulation by CCK and dopamine of the processing of reward-related stimuli within the NAS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8357529     DOI: 10.1016/0166-4328(93)90118-a

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  4 in total

1.  Devazepide, a CCKA receptor antagonist, impairs the acquisition of conditioned reward and conditioned activity.

Authors:  S A Josselyn; V P Franco; F J Vaccarino
Journal:  Psychopharmacology (Berl)       Date:  1996-01       Impact factor: 4.530

2.  Choice-selective sequences dominate in cortical relative to thalamic inputs to NAc to support reinforcement learning.

Authors:  Nathan F Parker; Avinash Baidya; Julia Cox; Laura M Haetzel; Anna Zhukovskaya; Malavika Murugan; Ben Engelhard; Mark S Goldman; Ilana B Witten
Journal:  Cell Rep       Date:  2022-05-17       Impact factor: 9.995

3.  Injection of 5-HT into the nucleus accumbens reduces the effects of d-amphetamine on responding for conditioned reward.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

4.  Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.

Authors:  Di Wen; Chun-Ling Ma; Ya-Jing Zhang; Yan-Xin Meng; Zhi-Yu Ni; Shu-Jin Li; Bin Cong
Journal:  BMC Neurosci       Date:  2012-06-08       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.